KALA BIO
KALA
22 hedge funds and large institutions have $4.88M invested in KALA BIO in 2024 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 8 reducing their positions, and 1 closing their positions.
100% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 1
32% more capital invested
Capital invested by funds: $3.69M → $4.88M (+$1.19M)
5% more funds holding
Funds holding: 21 → 22 (+1)
0.07% more ownership
Funds ownership: 0.39% → 0.46% (+0.07%)
63% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 8
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UOC
UBS O'Connor
Chicago,
Illinois
|
+$539K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$104K |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$99.9K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$11.1K |
| 5 |
Millennium Management
New York
|
+$5.57K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TRCT
Tower Research Capital (TRC)
New York
|
-$20.4K |
| 2 |
Renaissance Technologies
New York
|
-$20.1K |
| 3 |
Bank of America
Charlotte,
North Carolina
|
-$18.6K |
| 4 |
KOCAA
Knights of Columbus Asset Advisors
New Haven,
Connecticut
|
-$18.2K |
| 5 |
Morgan Stanley
New York
|
-$14.1K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Group One Trading
Chicago,
Illinois
| $24 | – | – | – |
|
27
Qube Research & Technologies (QRT)
London,
United Kingdom
| $24 | – | – | – |
|
|
PA
28
Parallel Advisors
San Francisco,
California
| $8 | – | – | – |
|
29
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | -$371 | -1 | Closed |
|
KALA Hedge Fund Activity: Q1 2024 in Review
22 of the 6,943 institutional investors tracked by Wall St. Rank reported a position in KALA BIO (KALA) for Q1 2024, worth a combined $4.88M — up 32% from $3.69M a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new KALA positions and 1 closed out — a net gain of 1 holder — while 3 added to existing stakes and 8 trimmed.
The largest buyer was UBS O'Connor, opening a new position worth an estimated $539K. The largest seller was Tower Research Capital (TRC), cutting an estimated $20.4K.
- 22 institutional investors held KALA BIO (KALA) as of Q1 2024, up from 21 in Q4 2023.
- Funds reported $4.88M of KALA BIO stock for Q1 2024, up 32% quarter-over-quarter.
- 2 funds opened new KALA BIO positions in Q1 2024 and 1 closed out, a net change of +1 holder.
- The largest KALA BIO buyer in Q1 2024 was UBS O'Connor, an estimated $539K added.
- The largest KALA BIO seller in Q1 2024 was Tower Research Capital (TRC), an estimated $20.4K sold.
Based on aggregated 13F filings for Q1 2024.